Atlas Trials

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Clinical trial NCT00081497 · COMPLETED

Trial details

NCT number
NCT00081497
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Fabry Disease
Start date
2004-01-01
Primary completion
2005-09-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.